Development of radiolabeling methods for the in vivo tracking of immune cells during adoptive cell therapy

Description of the granted funding

Adoptive cell therapy using cytotoxic, tumor-targeting immune cells has emerged as a promising treatment modality in select cancers. The aim of the project is to develop sensitive and quantitative nuclear molecular imaging tools for the tracking on transplanted immune cells and their progeny in a mouse model of metastatic melanoma. We propose to employ selective and fast bioorthogonal reactions to generate radiolabeled tracers based on direct labeling of transplanted cells, growth factors, and antibodies. The research will provide important tools for the monitoring of the success of ACT in living systems, and for the development of safer and more effective ACT therapies.
Show more

Starting year

2018

End year

2023

Granted funding

Mirkka Sarparanta Orcid -palvelun logo
438 874 €

Related funding decisions

346122
Research costs of Academy Research Fellows(2021)
159 997 €
320102
Research costs of Academy Research Fellows(2018)
209 980 €

Funder

Research Council of Finland

Funding instrument

Academy research fellows

Other information

Funding decision number

318422

Fields of science

Chemical sciences

Research fields

Kemia

Identified topics

cancer